András Váradi

András Váradi

Auto-generated profile, based on publicly available information

András Váradi

Institute of Enzymology, Hungarian Academy of Sciences, Budapest, Hungary

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2020 in FEBS Letters
Verified
Journal Article
Open access
PDF file
CTChristoph Thomas
Christoph Thomas
SAStephen Aller
Stephen Aller
KBKonstantinos Beis
Konstantinos Beis
ECElisabeth P. Carpenter
Elisabeth P. Carpenter
GCGeoffrey Chang
Geoffrey Chang
RTRobert Tampé
Robert Tampé
Members of the ATP‐binding cassette (ABC) transporter superfamily translocate a broad spectrum of chemically diverse substrates. While their eponymous ATP‐binding cassette in the nucleotide‐binding domains (NBDs) is highly conserved, their transmembrane domains (TMDs) forming the translocation pathway exhibit distinct folds and topologies, suggesting that during evolution the ancient motor domains were combined with different transmembrane mechanical systems to orchestrate a variety of cellular processes. In recent years, it has become increasingly evident that the distinct TMD folds are best suited to categorize the multitude of ABC transporters. We therefore propose a new ABC transporter classification that is based on structural homology in the TMDs.

12 July 2017 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
DDDóra Dedinszki
Dóra Dedinszki
Flora SzeriFlora Szeri
Flora Szeri
EKEszter Kozák
Eszter Kozák
VPViola Pomozi
Viola Pomozi
NTNatália Tőkési
Natália Tőkési
AVAndrás Váradi
András Váradi
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

5 October 2006 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
TATamás Arányi
Tamás Arányi
AVAndrás Váradi
András Váradi
Istvan SimonIstvan Simon
Istvan Simon
GTGábor E Tusnády
Gábor E Tusnády
Background: A large number of PCR primer-design softwares are available online. However, only very few of them can be used for the design of primers to amplify bisulfite-treated DNA templates, necessary to determine genomic DNA methylation profiles. Indeed, the number of studies on bisulfite-treated templates exponentially increases as determining DNA methylation becomes more important in the diagnosis of cancers. Bisulfite-treated DNA is difficult to amplify since undesired PCR products are often amplified due to the increased sequence redundancy after the chemical conversion. In order to increase the efficiency of PCR primer-design, we have developed BiSearch web server, an online primer-design tool for both bisulfite-treated and native DNA templates. Results: The web tool is composed of a primer-design and an electronic PCR (ePCR) algorithm. The completely reformulated ePCR module detects potential mispriming sites as well as undesired PCR products on both cDNA and native or bisulfite-treated genomic DNA libraries. Due to the new algorithm of the current version, the ePCR module became approximately hundred times faster than the previous one and gave the best performance when compared to other web based tools. This high-speed ePCR analysis made possible the development of the new option of high-throughput primer screening. BiSearch web server can be used for academic researchers at the http://bisearch.enzim.hu site. Conclusion: BiSearch web server is a useful tool for primer-design for any DNA template and especially for bisulfite-treated genomes. The ePCR tool for fast detection of mispriming sites and alternative PCR products in cDNA libraries and native or bisulfite-treated genomes are the unique features of the new version of BiSearch software.

14 September 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
OSOlivier Le Saux
Olivier Le Saux
KFKrisztina Fülöp
Krisztina Fülöp
YYYukiko Yamaguchi
Yukiko Yamaguchi
AIAttila Iliás
Attila Iliás
ZSZalán Szabó
Zalán Szabó
AVAndrás Váradi
András Váradi
Loss-of-function mutations in ABCC6 can cause chronic or acute forms of dystrophic mineralization described in disease models such as pseudoxanthoma elasticum (OMIM 26480) in human and dystrophic cardiac calcification in mice. The ABCC6 protein is a large membrane-embedded organic anion transporter primarily found in the plasma membrane of hepatocytes. We have established a complex experimental strategy to determine the structural and functional consequences of disease-causing mutations in the human ABCC6. The major aim of our study was to identify mutants with preserved transport activity but failure in intracellular targeting. Five missense mutations were investigated: R1138Q, V1298F, R1314W, G1321S and R1339C. Using in vitro assays, we have identified two variants; R1138Q and R1314W that retained significant transport activity. All mutants were transiently expressed in vivo, in mouse liver via hydrodynamic tail vein injections. The inactive V1298F was the only mutant that showed normal cellular localization in liver hepatocytes while the other mutants showed mostly intracellular accumulation indicating abnormal trafficking. As both R1138Q and R1314W displayed endoplasmic reticulum localization, we tested whether 4-phenylbutyrate (4-PBA), a drug approved for clinical use, could restore their intracellular trafficking to the plasma membrane in MDCKII and mouse liver. The cellular localization of R1314W was significantly improved by 4-PBA treatment, thus potentially rescuing its physiological function. Our work demonstrates the feasibility of the in vivo rescue of cellular maturation of some ABCC6 mutants in physiological conditions very similar to the biology of the fully differentiated human liver and could have future human therapeutic application.

1 February 2005 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Closed access
CÖCsilla Özvegy-Laczka
Csilla Özvegy-Laczka
GKGabriella Köblös
Gabriella Köblös
BSBalázs Sarkadi
Balázs Sarkadi
AVAndrás Váradi
András Váradi

1 January 2012 in Frontiers in Genetics
Verified
Journal Article
Open access
OSOlivier Le Saux
Olivier Le Saux
LMLudovic Martin
Ludovic Martin
ZAZouhair Aherrahrou
Zouhair Aherrahrou
GLGeorges LEFTHERIOTIS
Georges LEFTHERIOTIS
AVAndrás Váradi
András Váradi
CBChristopher N. Brampton
Christopher N. Brampton
Abnormal mineralization occurs in the context of several common conditions, including advanced age, diabetes, hypercholesterolemia, chronic renal failure, and certain genetic conditions. Metabolic, mechanical, infectious, and inflammatory injuries promote ectopic mineralization through overlapping yet distinct molecular mechanisms of initiation and progression. The ABCC6 protein is an ATP-dependent transporter primarily found in the plasma membrane of hepatocytes. ABCC6 exports unknown substrates from the liver presumably for systemic circulation. ABCC6 deficiency is the primary cause for chronic and acute forms of ectopic mineralization described in diseases such as pseudoxanthoma elasticum (PXE), β-thalassemia, and generalized arterial calcification of infancy (GACI) in humans and dystrophic cardiac calcification (DCC) in mice. These pathologies are characterized by mineralization of cardiovascular, ocular, and dermal tissues. PXE and to an extent GACI are caused by inactivating ABCC6 mutations, whereas the mineralization associated with β-thalassemia patients derives from a liver-specific change in ABCC6 expression. DCC is an acquired phenotype resulting from cardiovascular insults (ischemic injury or hyperlipidemia) and secondary to ABCC6 insufficiency. Abcc6-deficient mice develop ectopic calcifications similar to both the human PXE and mouse DCC phenotypes. The precise molecular and cellular mechanism linking deficient hepatic ABCC6 function to distal ectopic mineral deposition is not understood and has captured the attention of many research groups. Our previously published work along with that of others show that ABCC6 influences other modulators of calcification and that it plays a much greater physiological role than originally thought.